Evidence map›Paper›PMID 38897829›Full record

ReviewSeminars in perinatology2024

Impact of SARS-CoV-2 infection during pregnancy on the placenta and fetus.

Amanda Li, David A Schwartz, Andrew Vo, Roslyn VanAbel, Celeste Coler, Edmunda Li, Bryan Lukman, Briana Del Rosario, Ashley Vong, Miranda Li and 1 more

Abstract readReview
In one paragraph

Review in Seminars in perinatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Amanda LiDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America.
David A SchwartzPerinatal Pathology Consulting, Atlanta, Georgia, United States of America.
Andrew VoDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America.
Roslyn VanAbelDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America.
Celeste ColerDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America; School of Medicine, University of Washington, Seattle, Washington, United States of America.
Edmunda LiDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America.
Bryan LukmanDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America.
Briana Del RosarioDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America.
Ashley VongDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America.
Miranda LiDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America; School of Medicine, University of Washington, Seattle, Washington, United States of America.
Kristina M Adams WaldorfDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States of America; School of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Global Health, University of Washington, Seattle, Washington, United States of America. Electronic address: adamsk@uw.edu.

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
WaNPRC Macaca nemestrina SPF Breeding ColonyU42OD011123 · OD · UNIVERSITY OF WASHINGTON · PI CHARLOTTE HOTCHKISS · 2012 to 2026
$34.4M
JAK-STAT Control of Zika Virus-Induced Fetal InjuryR01AI143265 · NIAID · UNIVERSITY OF WASHINGTON · PI ADAMS WALDORF, KRISTINA M., GALE, MICHAEL · 2019 to 2023
$4.6M
Immune Control of Group B Streptococcal PlacentalR01AI145890 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2019 to 2023
$4.4M
Influenza pathogenesis in pregnancyR01AI164588 · NIAID · UNIVERSITY OF WASHINGTON · PI ADAMS WALDORF, KRISTINA M. · 2021 to 2025
$4.2M
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm BirthR01HD098713 · NICHD · UNIVERSITY OF WASHINGTON · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2020 to 2024
$3.8M
Impact of Zika Virus Infection on Fetal Innate and Adaptive ImmunityR01AI176777 · NIAID · UNIVERSITY OF WASHINGTON · PI Kristina M. Adams Waldorf · 2024 to 2026
$2.5M
NIAID NIH HHS R01 AI143265NIAID NIH HHS R01 AI145890NIAID NIH HHS R01 AI164588NIAID NIH HHS R01 AI176777NICHD NIH HHS R01 HD098713NIH HHS P51 OD010425NIH HHS U42 OD011123
6 · The paper itself

Abstract

Pregnant people and their fetuses are vulnerable to adverse health outcomes from coronavirus 2019 disease (COVID-19) due to infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has been associated with higher rates of maternal mortality, preterm birth, and stillbirth. While SARS-CoV-2 infection of the placenta and vertical transmission is rare, this may be due to the typically longer time interval between maternal infection and testing of the placenta and neonate. Placental injury is evident in cases of SARS-CoV-2-associated stillbirth with massive perivillous fibrin deposition, chronic histiocytic intervillositis, and trophoblast necrosis. Maternal COVID-19 can also polarize fetal immunity, which may have long-term effects on neurodevelopment. Although the COVID-19 pandemic continues to evolve, the impact of emerging SARS-CoV-2 variants on placental and perinatal injury/mortality remains concerning for maternal and perinatal health. Here, we highlight the impact of COVID-19 on the placenta and fetus and remaining knowledge gaps.

Indexed as

COVID-19Infectious Disease Transmission, VerticalPlacentaPregnancy Complications, InfectiousSARS-CoV-2FemaleFetusHumansInfant, NewbornPlacenta DiseasesPregnancyPremature BirthStillbirthCoronavirusCOVID-19FetusImmune responseMaternal mortalityPlacentaPregnancyPreterm birthSARS-CoV-2StillbirthVertical transmission

Identifiers

PMID38897829
PMCPMC11288977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.